These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
359 related articles for article (PubMed ID: 23200016)
1. Comparative characterization of the cellular uptake and photodynamic efficiency of Foscan® and Fospeg in a human prostate cancer cell line. Petri A; Yova D; Alexandratou E; Kyriazi M; Rallis M Photodiagnosis Photodyn Ther; 2012 Dec; 9(4):344-54. PubMed ID: 23200016 [TBL] [Abstract][Full Text] [Related]
2. Photochemical internalization (PCI)-mediated enhancement of bleomycin cytotoxicity by liposomal mTHPC formulations in human head and neck cancer cells. Peng W; Samplonius DF; de Visscher S; Roodenburg JL; Helfrich W; Witjes MJ Lasers Surg Med; 2014 Oct; 46(8):650-8. PubMed ID: 25174329 [TBL] [Abstract][Full Text] [Related]
3. Improved in vivo delivery of m-THPC via pegylated liposomes for use in photodynamic therapy. Bovis MJ; Woodhams JH; Loizidou M; Scheglmann D; Bown SG; Macrobert AJ J Control Release; 2012 Jan; 157(2):196-205. PubMed ID: 21982898 [TBL] [Abstract][Full Text] [Related]
4. Uptake and photo-toxicity of Foscan®, Foslip® and Fospeg® in multicellular tumor spheroids. Gaio E; Scheglmann D; Reddi E; Moret F J Photochem Photobiol B; 2016 Aug; 161():244-52. PubMed ID: 27285816 [TBL] [Abstract][Full Text] [Related]
5. Optimizing photodynamic therapy: in vivo pharmacokinetics of liposomal meta-(tetrahydroxyphenyl)chlorin in feline squamous cell carcinoma. Buchholz J; Kaser-Hotz B; Khan T; Rohrer Bley C; Melzer K; Schwendener RA; Roos M; Walt H Clin Cancer Res; 2005 Oct; 11(20):7538-44. PubMed ID: 16243829 [TBL] [Abstract][Full Text] [Related]
6. FosPeg® PDT alters the EBV miRNAs and LMP1 protein expression in EBV positive nasopharyngeal carcinoma cells. Wu RW; Chu ES; Huang Z; Xu CS; Ip CW; Yow CM J Photochem Photobiol B; 2013 Oct; 127():114-22. PubMed ID: 24013466 [TBL] [Abstract][Full Text] [Related]
7. Localization of liposomal mTHPC formulations within normal epithelium, dysplastic tissue, and carcinoma of oral epithelium in the 4NQO-carcinogenesis rat model. de Visscher SA; Witjes MJ; van der Vegt B; de Bruijn HS; van der Ploeg-van den Heuvel A; Amelink A; Sterenborg HJ; Roodenburg JL; Robinson DJ Lasers Surg Med; 2013 Dec; 45(10):668-78. PubMed ID: 24174342 [TBL] [Abstract][Full Text] [Related]
8. Meta-tetra(hydroxyphenyl)chlorin-loaded liposomes sterically stabilised with poly(ethylene glycol) of different length and density: characterisation, in vitro cellular uptake and phototoxicity. Compagnin C; Moret F; Celotti L; Miotto G; Woodhams JH; MacRobert AJ; Scheglmann D; Iratni S; Reddi E Photochem Photobiol Sci; 2011 Nov; 10(11):1751-9. PubMed ID: 21874194 [TBL] [Abstract][Full Text] [Related]
9. Fluorescence localization and kinetics of mTHPC and liposomal formulations of mTHPC in the window-chamber tumor model. de Visscher SA; Kaščáková S; de Bruijn HS; van den Heuvel Av; Amelink A; Sterenborg HJ; Robinson DJ; Roodenburg JL; Witjes MJ Lasers Surg Med; 2011 Aug; 43(6):528-36. PubMed ID: 21761424 [TBL] [Abstract][Full Text] [Related]
10. Foscan-based photodynamic treatment in vivo: correlation between efficacy and Foscan accumulation in tumor, plasma and leukocytes. Maugain E; Sasnouski S; Zorin V; Merlin JL; Guillemin F; Bezdetnaya L Oncol Rep; 2004 Sep; 12(3):639-45. PubMed ID: 15289849 [TBL] [Abstract][Full Text] [Related]
11. Redistribution of meta-tetra(hydroxyphenyl)chlorin (m-THPC) from conventional and PEGylated liposomes to biological substrates. Reshetov V; Kachatkou D; Shmigol T; Zorin V; D'Hallewin MA; Guillemin F; Bezdetnaya L Photochem Photobiol Sci; 2011 Jun; 10(6):911-9. PubMed ID: 21311777 [TBL] [Abstract][Full Text] [Related]
12. Comparative characterization of the efficiency and cellular pharmacokinetics of Foscan- and Foslip-based photodynamic treatment in human biliary tract cancer cell lines. Kiesslich T; Berlanda J; Plaetzer K; Krammer B; Berr F Photochem Photobiol Sci; 2007 Jun; 6(6):619-27. PubMed ID: 17549263 [TBL] [Abstract][Full Text] [Related]
13. Transferrin conjugation does not increase the efficiency of liposomal Foscan during in vitro photodynamic therapy of oesophageal cancer. Paszko E; Vaz GM; Ehrhardt C; Senge MO Eur J Pharm Sci; 2013 Jan; 48(1-2):202-10. PubMed ID: 23159666 [TBL] [Abstract][Full Text] [Related]
14. Interaction of liposomal formulations of meta-tetra(hydroxyphenyl)chlorin (temoporfin) with serum proteins: protein binding and liposome destruction. Reshetov V; Zorin V; Siupa A; D'Hallewin MA; Guillemin F; Bezdetnaya L Photochem Photobiol; 2012; 88(5):1256-64. PubMed ID: 22607362 [TBL] [Abstract][Full Text] [Related]
15. Effect of FosPeg® mediated photoactivation on P-gp/ABCB1 protein expression in human nasopharyngeal carcinoma cells. Wu RWK; Chu ESM; Huang Z; Xu CS; Ip CW; Yow CMN J Photochem Photobiol B; 2015 Jul; 148():82-87. PubMed ID: 25900553 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic and biodistribution study following systemic administration of Fospeg®--a Pegylated liposomal mTHPC formulation in a murine model. Xie H; Svenmarker P; Axelsson J; Gräfe S; Kyriazi M; Bendsoe N; Andersson-Engels S; Svanberg K J Biophotonics; 2015 Jan; 8(1-2):142-52. PubMed ID: 24375973 [TBL] [Abstract][Full Text] [Related]
17. Photodynamic therapy with conventional and PEGylated liposomal formulations of mTHPC (temoporfin): comparison of treatment efficacy and distribution characteristics in vivo. Reshetov V; Lassalle HP; François A; Dumas D; Hupont S; Gräfe S; Filipe V; Jiskoot W; Guillemin F; Zorin V; Bezdetnaya L Int J Nanomedicine; 2013; 8():3817-31. PubMed ID: 24143087 [TBL] [Abstract][Full Text] [Related]
18. Cellular and molecular effects of the liposomal mTHPC derivative Foslipos in prostate carcinoma cells in vitro. Gyenge EB; Hiestand S; Graefe S; Walt H; Maake C Photodiagnosis Photodyn Ther; 2011 Jun; 8(2):86-96. PubMed ID: 21497299 [TBL] [Abstract][Full Text] [Related]
19. Novel nanostructural photosensitizers for photodynamic therapy: in vitro studies. Nawalany K; Rusin A; Kepczynski M; Filipczak P; Kumorek M; Kozik B; Weitman H; Ehrenberg B; Krawczyk Z; Nowakowska M Int J Pharm; 2012 Jul; 430(1-2):129-40. PubMed ID: 22525077 [TBL] [Abstract][Full Text] [Related]
20. Combination of Fospeg-IPDT and a natural antioxidant compound prevents photosensitivity in a murine prostate cancer tumour model. Petri A; Alexandratou E; Kyriazi M; Rallis M; Roussis V; Yova D Photodiagnosis Photodyn Ther; 2012 Jun; 9(2):100-8. PubMed ID: 22594979 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]